Stay updated on SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial

Sign up to get notified when there's something new on the SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating a recent update in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-05-22T07:49:50.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 03 29 to 05 08, indicating a recent update in the study details related to safety and efficacy with SAR445514 in participants with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Light-chain Amyloidosis.
    Difference
    0.7%
    Check dated 2024-05-09T01:46:48.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:33:04.000Z thumbnail image

Stay in the know with updates to SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAR445514 Safety & Efficacy in RRMM and RRLCA Clinical Trial page.